Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Oct;81(3):409–415. doi: 10.1038/sj.bjc.6690709

Identification of tumour-associated and germ line p53 mutations in canine mammary cancer

N Veldhoen 1, J Watterson 1, M Brash 2, J Milner 1
PMCID: PMC2362910  PMID: 10507764

Abstract

Mutations of the tumour suppressor p53 gene are found in a number of spontaneous canine cancers and may contribute to increased cytogenetic alterations and tumour formation. Using reverse transcription and DNA amplification, we isolated p53 cDNA from normal and tumour tissue of ten canine mammary cancer patients. DNA sequencing identified p53 mutations in three of the ten patients. These included tumour-associated p53 gene mutations within exons 2 and 5 and a germ line deletion of exons 3 to 7. These results support a role for p53 inactivation in canine mammary tumour formation and breed predisposition to cancer. Such information could prove invaluable in the successful outbreeding of inherited predisposition to cancer in the dog. A putative polymorphism was also identified at codon 69 in exon 4 and we discuss the possibility that similar polymorphisms may be associated with human breast cancer. © 1999 Cancer Research Campaign

Keywords: germline, DNA mutation, canine p53, mammary cancer

Full Text

The Full Text of this article is available as a PDF (178.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ara S., Lee P. S., Hansen M. F., Saya H. Codon 72 polymorphism of the TP53 gene. Nucleic Acids Res. 1990 Aug 25;18(16):4961–4961. doi: 10.1093/nar/18.16.4961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Berns E. M., Klijn J. G., Smid M., van Staveren I. L., Look M. P., van Putten W. L., Foekens J. A. TP53 and MYC gene alterations independently predict poor prognosis in breast cancer patients. Genes Chromosomes Cancer. 1996 Jul;16(3):170–179. doi: 10.1002/(SICI)1098-2264(199607)16:3<170::AID-GCC3>3.0.CO;2-W. [DOI] [PubMed] [Google Scholar]
  3. Birch J. M., Blair V., Kelsey A. M., Evans D. G., Harris M., Tricker K. J., Varley J. M. Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome. Oncogene. 1998 Sep 3;17(9):1061–1068. doi: 10.1038/sj.onc.1202033. [DOI] [PubMed] [Google Scholar]
  4. Béroud C., Soussi T. p53 gene mutation: software and database. Nucleic Acids Res. 1998 Jan 1;26(1):200–204. doi: 10.1093/nar/26.1.200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Casey G., Lopez M. E., Ramos J. C., Plummer S. J., Arboleda M. J., Shaughnessy M., Karlan B., Slamon D. J. DNA sequence analysis of exons 2 through 11 and immunohistochemical staining are required to detect all known p53 alterations in human malignancies. Oncogene. 1996 Nov 7;13(9):1971–1981. [PubMed] [Google Scholar]
  6. Chang H., Benchimol S., Minden M. D., Messner H. A. Alterations of p53 and c-myc in the clonal evolution of malignant lymphoma. Blood. 1994 Jan 15;83(2):452–459. [PubMed] [Google Scholar]
  7. Chu L. L., Rutteman G. R., Kong J. M., Ghahremani M., Schmeing M., Misdorp W., van Garderen E., Pelletier J. Genomic organization of the canine p53 gene and its mutational status in canine mammary neoplasia. Breast Cancer Res Treat. 1998 Jul;50(1):11–25. doi: 10.1023/a:1006010526813. [DOI] [PubMed] [Google Scholar]
  8. Cook A., Milner J. Evidence for allosteric variants of wild-type p53, a tumour suppressor protein. Br J Cancer. 1990 Apr;61(4):548–552. doi: 10.1038/bjc.1990.123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Devilee P., Van Leeuwen I. S., Voesten A., Rutteman G. R., Vos J. H., Cornelisse C. J. The canine p53 gene is subject to somatic mutations in thypoid carcinoma. Anticancer Res. 1994 Sep-Oct;14(5A):2039–2046. [PubMed] [Google Scholar]
  10. Faille A., De Cremoux P., Extra J. M., Linares G., Espie M., Bourstyn E., De Rocquancourt A., Giacchetti S., Marty M., Calvo F. p53 mutations and overexpression in locally advanced breast cancers. Br J Cancer. 1994 Jun;69(6):1145–1150. doi: 10.1038/bjc.1994.225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gamble J., Milner J. Evidence that immunological variants of p53 represent alternative protein conformations. Virology. 1988 Feb;162(2):452–458. doi: 10.1016/0042-6822(88)90486-2. [DOI] [PubMed] [Google Scholar]
  12. Gannon J. V., Greaves R., Iggo R., Lane D. P. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J. 1990 May;9(5):1595–1602. doi: 10.1002/j.1460-2075.1990.tb08279.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Glebov O. K., McKenzie K. E., White C. A., Sukumar S. Frequent p53 gene mutations and novel alleles in familial breast cancer. Cancer Res. 1994 Jul 15;54(14):3703–3709. [PubMed] [Google Scholar]
  14. Hainaut P., Soussi T., Shomer B., Hollstein M., Greenblatt M., Hovig E., Harris C. C., Montesano R. Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects. Nucleic Acids Res. 1997 Jan 1;25(1):151–157. doi: 10.1093/nar/25.1.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hartmann A., Blaszyk H., Kovach J. S., Sommer S. S. The molecular epidemiology of p53 gene mutations in human breast cancer. Trends Genet. 1997 Jan;13(1):27–33. doi: 10.1016/s0168-9525(96)10043-3. [DOI] [PubMed] [Google Scholar]
  16. Helland A., Langerød A., Johnsen H., Olsen A. O., Skovlund E., Børresen-Dale A. L. p53 polymorphism and risk of cervical cancer. Nature. 1998 Dec 10;396(6711):530–532. doi: 10.1038/25034. [DOI] [PubMed] [Google Scholar]
  17. Hirano Y., Yamato K., Tsuchida N. A temperature sensitive mutant of the human p53, Val138, arrests rat cell growth without induced expression of cip1/waf1/sdi1 after temperature shift-down. Oncogene. 1995 May 18;10(10):1879–1885. [PubMed] [Google Scholar]
  18. Huang Y., Yin J., Meltzer S. J. A unique p53 intragenic deletion flanked by short direct repeats results in loss of mRNA expression in a human esophageal carcinoma. Carcinogenesis. 1994 Aug;15(8):1653–1655. doi: 10.1093/carcin/15.8.1653. [DOI] [PubMed] [Google Scholar]
  19. Johnson A. S., Couto C. G., Weghorst C. M. Mutation of the p53 tumor suppressor gene in spontaneously occurring osteosarcomas of the dog. Carcinogenesis. 1998 Jan;19(1):213–217. doi: 10.1093/carcin/19.1.213. [DOI] [PubMed] [Google Scholar]
  20. Kussie P. H., Gorina S., Marechal V., Elenbaas B., Moreau J., Levine A. J., Pavletich N. P. Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science. 1996 Nov 8;274(5289):948–953. doi: 10.1126/science.274.5289.948. [DOI] [PubMed] [Google Scholar]
  21. Lin J., Wu X., Chen J., Chang A., Levine A. J. Functions of the p53 protein in growth regulation and tumor suppression. Cold Spring Harb Symp Quant Biol. 1994;59:215–223. doi: 10.1101/sqb.1994.059.01.026. [DOI] [PubMed] [Google Scholar]
  22. MacVean D. W., Monlux A. W., Anderson P. S., Jr, Silberg S. L., Roszel J. F. Frequency of canine and feline tumors in a defined population. Vet Pathol. 1978 Nov;15(6):700–715. doi: 10.1177/030098587801500602. [DOI] [PubMed] [Google Scholar]
  23. Malkin D. Germline p53 mutations and heritable cancer. Annu Rev Genet. 1994;28:443–465. doi: 10.1146/annurev.ge.28.120194.002303. [DOI] [PubMed] [Google Scholar]
  24. Martinez J., Georgoff I., Martinez J., Levine A. J. Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev. 1991 Feb;5(2):151–159. doi: 10.1101/gad.5.2.151. [DOI] [PubMed] [Google Scholar]
  25. Mayr B., Dressler A., Reifinger M., Feil C. Cytogenetic alterations in eight mammary tumors and tumor-suppressor gene p53 mutation in one mammary tumor from dogs. Am J Vet Res. 1998 Jan;59(1):69–78. [PubMed] [Google Scholar]
  26. Mayr B., Schaffner W., Botto I., Reifinger M., Loupal G. Canine tumour suppressor gene p53--mutation in a case of adenoma of circumanal glands. Vet Res Commun. 1997 Jul;21(5):369–373. doi: 10.1023/a:1005820607258. [DOI] [PubMed] [Google Scholar]
  27. Mayr B., Schellander K., Schleger W., Reifinger M. Sequence of an exon of the canine p53 gene--mutation in a papilloma. Br Vet J. 1994 Jan-Feb;150(1):81–84. doi: 10.1016/S0007-1935(05)80099-5. [DOI] [PubMed] [Google Scholar]
  28. Minaguchi T., Kanamori Y., Matsushima M., Yoshikawa H., Taketani Y., Nakamura Y. No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus 16/18 infection. Cancer Res. 1998 Oct 15;58(20):4585–4586. [PubMed] [Google Scholar]
  29. Moll U. M., Riou G., Levine A. J. Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):7262–7266. doi: 10.1073/pnas.89.15.7262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Rolley N., Butcher S., Milner J. Specific DNA binding by different classes of human p53 mutants. Oncogene. 1995 Aug 17;11(4):763–770. [PubMed] [Google Scholar]
  31. Rosenthal A. N., Ryan A., Al-Jehani R. M., Storey A., Harwood C. A., Jacobs I. J. p53 codon 72 polymorphism and risk of cervical cancer in UK. Lancet. 1998 Sep 12;352(9131):871–872. doi: 10.1016/S0140-6736(98)07357-7. [DOI] [PubMed] [Google Scholar]
  32. Seth A., Palli D., Mariano J. M., Metcalf R., Venanzoni M. C., Bianchi S., Kottaridis S. D., Papas T. S. P53 gene mutations in women with breast cancer and a previous history of benign breast disease. Eur J Cancer. 1994;30A(6):808–812. doi: 10.1016/0959-8049(94)90297-6. [DOI] [PubMed] [Google Scholar]
  33. Storey A., Thomas M., Kalita A., Harwood C., Gardiol D., Mantovani F., Breuer J., Leigh I. M., Matlashewski G., Banks L. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature. 1998 May 21;393(6682):229–234. doi: 10.1038/30400. [DOI] [PubMed] [Google Scholar]
  34. Strauss B. S. Silent and multiple mutations in p53 and the question of the hypermutability of tumors. Carcinogenesis. 1997 Aug;18(8):1445–1452. doi: 10.1093/carcin/18.8.1445. [DOI] [PubMed] [Google Scholar]
  35. Sun X. F., Johannsson O., Håkansson S., Sellberg G., Nordenskjöld B., Olsson H., Borg A. A novel p53 germline alteration identified in a late onset breast cancer kindred. Oncogene. 1996 Jul 18;13(2):407–411. [PubMed] [Google Scholar]
  36. Tagawa M., Murata M., Kimura H. Prognostic value of mutations and a germ line polymorphism of the p53 gene in non-small cell lung carcinoma: association with clinicopathological features. Cancer Lett. 1998 Jun 5;128(1):93–99. doi: 10.1016/s0304-3835(98)00056-1. [DOI] [PubMed] [Google Scholar]
  37. Tornaletti S., Pfeifer G. P. Complete and tissue-independent methylation of CpG sites in the p53 gene: implications for mutations in human cancers. Oncogene. 1995 Apr 20;10(8):1493–1499. [PubMed] [Google Scholar]
  38. Van Leeuwen I. S., Hellmèn E., Cornelisse C. J., Van den Burgh B., Rutteman G. R. P53 mutations in mammary tumor cell lines and corresponding tumor tissues in the dog. Anticancer Res. 1996 Nov-Dec;16(6B):3737–3744. [PubMed] [Google Scholar]
  39. Veldhoen N., Milner J. Isolation of canine p53 cDNA and detailed characterization of the full length canine p53 protein. Oncogene. 1998 Feb 26;16(8):1077–1084. doi: 10.1038/sj.onc.1201863. [DOI] [PubMed] [Google Scholar]
  40. Veldhoen N., Stewart J., Brown R., Milner J. Mutations of the p53 gene in canine lymphoma and evidence for germ line p53 mutations in the dog. Oncogene. 1998 Jan 15;16(2):249–255. doi: 10.1038/sj.onc.1201489. [DOI] [PubMed] [Google Scholar]
  41. Venkatachalam S., Shi Y. P., Jones S. N., Vogel H., Bradley A., Pinkel D., Donehower L. A. Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation. EMBO J. 1998 Aug 17;17(16):4657–4667. doi: 10.1093/emboj/17.16.4657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Wada H., Asada M., Nakazawa S., Itoh H., Kobayashi Y., Inoue T., Fukumuro K., Chan L. C., Sugita K., Hanada R. Clonal expansion of p53 mutant cells in leukemia progression in vitro. Leukemia. 1994 Jan;8(1):53–59. [PubMed] [Google Scholar]
  43. Yamato K., Yamamoto M., Hirano Y., Tsuchida N. A human temperature-sensitive p53 mutant p53Val-138: modulation of the cell cycle, viability and expression of p53-responsive genes. Oncogene. 1995 Jul 6;11(1):1–6. [PubMed] [Google Scholar]
  44. van Leeuwen I. S., Cornelisse C. J., Misdorp W., Goedegebuure S. A., Kirpensteijn J., Rutteman G. R. P53 gene mutations in osteosarcomas in the dog. Cancer Lett. 1997 Jan 1;111(1-2):173–178. doi: 10.1016/s0304-3835(96)04529-6. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES